Prosecution Insights
Last updated: August 18, 2026

Examiner: SALMON, KATHERINE D

Tech Center 1600 • Art Units: 1634 1671 1682 1683

This examiner grants 43% of resolved cases

Performance Statistics

42.6%
Allow Rate
-17.4% vs TC avg
900
Total Applications
+38.0%
Interview Lift
1469
Avg Prosecution Days
Based on 792 resolved cases, 2023–2026

Rejection Statute Breakdown

19.4%
§101 Eligibility
11.3%
§102 Novelty
28.2%
§103 Obviousness
35.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18050855 METHODS AND SYSTEMS FOR IMPROVING PATIENT MONITORING AFTER SURGERY Non-Final OA GUARDANT HEALTH, INC.
17489677 METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS Non-Final OA GUARDANT HEALTH, INC.
16309271 COMPOSITIONS AND METHODS FOR DETECTION OF NUCLEIC ACID MUTATIONS Final Rejection Natera, Inc.
18174491 BREAST CANCER-RESPONSE PREDICTION SUBTYPES Non-Final OA The Regents of The University of California
16848989 NONINVASIVE DIAGNOSTICS BY SEQUENCING 5-HYDROXYMETHYLATED CELL-FREE DNA Final Rejection The Board of Trustees of the Leland Stanford Junior University
17984444 SURFACE-ENHANCED RAMAN SCATTERING (SERS) BIOSENSOR FOR DIAGNOSING PROSTATE CANCER WITH HIGH SENSITIVITY Non-Final OA Korea University Research and Business Foundation
18152346 Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Variants And Uses Thereof Final Rejection Regeneron Pharmaceuticals, Inc.
18595057 DIAGNOSIS OF ACUTE AND CHRONIC LUNG DISEASES BY QUANTIFYING SPINK1 LEVEL Non-Final OA Northwestern University
18548175 CELL-FREE BIOSENSORS WITH DNA STRAND DISPLACEMENT CIRCUITS Non-Final OA Northwestern University
18023538 CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS FOR VIRUS DETECTION Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
18463282 USE OF SDHA AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN UVEAL MELANOMA Final Rejection Board of Regents, The University of Texas System
18269171 SELECTIVE LYSIS OF HUMAN BLOOD CELLS Final Rejection Roche Molecular Systems, Inc.
18276223 BIOMARKERS FOR CANCER TREATMENT Non-Final OA Foundation Medicine, Inc.
18575242 ANALOG CIRCUIT TO COMPENSATE BIAS OFFSET IN AMPLIFIER ARRAY Non-Final OA ILLUMINA, INC.
18013178 METHOD FOR DETECTING COLORECTAL CANCER Non-Final OA ACADEMISCH ZIEKENHUIS MAASTRICHT
16633183 NEW SUBPOPULATIONS OF CANCER ASSOCIATED FIBROBLASTS AS PROGNOSIS MARKERS FOR IMMUNOTHERAPY TREATMENTS Final Rejection INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
18509538 Method for Detecting Thyroid Tumor Based on Imprinted Gene Analysis Non-Final OA LISEN IMPRINTING DIAGNOSTICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month